AbbVie, Inc. (ABBV)
256.46
-3.75
(-1.44%)
USD |
NYSE |
Sep 04, 16:00
256.40
-0.06
(-0.02%)
After-Hours: 20:00
AbbVie Net Income (TTM) : 6.274B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.274B |
| March 31, 2026 | 3.601B |
| December 31, 2025 | 4.193B |
| September 30, 2025 | 2.355B |
| June 30, 2025 | 3.731B |
| March 31, 2025 | 4.163B |
| December 31, 2024 | 4.246B |
| September 30, 2024 | 5.092B |
| June 30, 2024 | 5.308B |
| March 31, 2024 | 5.961B |
| December 31, 2023 | 4.829B |
| September 30, 2023 | 6.488B |
| June 30, 2023 | 8.652B |
| March 31, 2023 | 7.553B |
| December 31, 2022 | 11.79B |
| September 30, 2022 | 13.35B |
| June 30, 2022 | 12.57B |
| March 31, 2022 | 12.41B |
| December 31, 2021 | 11.47B |
| September 30, 2021 | 7.464B |
| June 30, 2021 | 6.601B |
| March 31, 2021 | 5.092B |
| December 31, 2020 | 4.557B |
| September 30, 2020 | 7.323B |
| June 30, 2020 | 6.901B |
| Date | Value |
|---|---|
| March 31, 2020 | 8.391B |
| December 31, 2019 | 7.839B |
| September 30, 2019 | 3.229B |
| June 30, 2019 | 4.09B |
| March 31, 2019 | 5.33B |
| December 31, 2018 | 5.657B |
| September 30, 2018 | 7.531B |
| June 30, 2018 | 6.419B |
| March 31, 2018 | 6.352B |
| December 31, 2017 | 5.283B |
| September 30, 2017 | 6.615B |
| June 30, 2017 | 6.582B |
| March 31, 2017 | 6.278B |
| December 31, 2016 | 5.923B |
| September 30, 2016 | 6.048B |
| June 30, 2016 | 5.69B |
| March 31, 2016 | 5.447B |
| December 31, 2015 | 5.117B |
| September 30, 2015 | 2.803B |
| June 30, 2015 | 2.074B |
| March 31, 2015 | 1.806B |
| December 31, 2014 | 1.765B |
| September 30, 2014 | 3.689B |
| June 30, 2014 | 4.144B |
| March 31, 2014 | 4.121B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Biogen, Inc. | 834.60M |
| Gilead Sciences, Inc. | -3.24B |
| Regeneron Pharmaceuticals, Inc. | 4.329B |
| Amgen, Inc. | 8.743B |
| REGENXBIO, Inc. | -196.43M |